RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
8.85
+0.22 (2.55%)
Feb 23, 2026, 4:00 PM EST - Market closed

RxSight Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
3641,3861,446351308-
Market Cap Growth
-73.65%-4.17%311.68%14.14%--
Enterprise Value
1481,1601,317284185-
Last Close Price
8.8534.3840.3212.6711.25-
PS Ratio
2.569.9016.237.1713.62-
PB Ratio
1.324.939.023.912.23-
P/TBV Ratio
1.324.939.023.912.23-
EV/Sales Ratio
1.048.2914.795.798.17-
Debt / Equity Ratio
0.040.040.020.500.33-0.40
Net Debt / Equity Ratio
-0.78-0.80-0.77-0.68-0.830.50
Net Debt / EBITDA Ratio
5.086.762.701.022.341.21
Net Debt / FCF Ratio
9.7310.052.680.992.451.01
Asset Turnover
0.460.560.540.290.150.14
Inventory Turnover
1.412.082.192.422.221.67
Quick Ratio
11.2910.337.066.7714.826.19
Current Ratio
12.7411.368.067.8115.927.03
Return on Equity (ROE)
-12.92%-12.43%-38.84%-58.52%-159.76%-
Return on Assets (ROA)
-9.18%-9.19%-18.82%-23.08%-22.49%-20.96%
Return on Invested Capital (ROIC)
-74.41%-79.69%-153.43%-239.23%--
Return on Capital Employed (ROCE)
-15.90%-12.60%-31.00%-47.60%-29.10%-39.70%
Earnings Yield
-9.82%-1.98%-3.36%-19.01%-15.82%-
FCF Yield
-6.10%-1.62%-3.21%-17.44%-15.16%-
Buyback Yield / Dilution
-7.62%-12.81%-24.56%-103.02%-146.28%73.12%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q